Kunstler: Warmonger's Remorse By James Howard Kunstler

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
169
Kunstler: Warmonger's Remorse

By James Howard Kunstler
April 13, 2018

I don’t know about you, but for a couple of days there I expected to wake up to the sight of mushroom clouds billowing across the horizon, all our exceptional hopes, wishes, troubles, and cares as a nation gone up in a vapor of smoking plastic. I think it was the Defense Secretary, nickname “Mad Dog,” who put the kibosh on the latest neocon temper tantrum against Bashar “The Animal” al-Assad. General Mattis told the House Armed Services Committee that the US was, er, “still looking for evidence” of an alleged poison gas attack against civilians in Douma, Syria.

That phrase “still looking for evidence” sounds like an elliptical way of saying we have no idea what, if anything, might have actually happened over there, just possibly even nothing at all. The Russians were busy looking for evidence on the ground in and around Douma, and they claimed to have found nothing — no traces of poison gas, no corpses, no gassing victims in the local hospital — and put out a call for international inspectors to come have a look. No reply on that from our side. Which does raise the question: are we even interested in the truth?

Maybe not. Also apparently not in the strange case of the poisoned Skripals that preceded the incident (or not) at Douma, and which touched off an expulsion orgy of Russian Diplomats among the US and our allies. Sergei Skripal, a Russian/British double-agent who had been exchanged to Britain in a spy-swap, fell ill along with his daughter, Yulia, on a park bench after lunching in quaint old Salisbury, Wiltshire, UK. The supposed weapon in that case, Novichok, an advanced neurotoxin that kills instantly, was found on the doorknob of the Skripal house, and yet the couple made it downtown, enjoyed a leisurely meal, and took a post-luncheon stroll. Casual observers did note that Salisbury is only a ten-minute drive from the UK’s Defence Science and Technology Laboratory, where military poisons are stored and evaluated, and after two weeks of idle chatter, scientists there released a galling report that they could not determine the origin of whatever knocked out the Skripals.

In any case, it didn’t kill them. Yulia Skripal was released from the hospital this week and is, apparently, some sort of hostage of the British government. You’d suppose that in a free country, Yulia might be interested in talking to the press, and certainly vice-versa, but she is incommunicado and was whisked away under guard to some mysterious hideaway. Sergei, we’re told, is coming out of it, too, in his hospital room, and seems to have nothing to say, either. There was chatter in the US media that the Skripals might be sent here under some sort of US witness protection program. It looks like the US and Britain are running out of rugs to sweep stuff under.

Clownish as it was, the Skripal affair ramped up already poor relations between Russia and the West (mainly the US) to code red levels, as perhaps intended by the dream factory known as the Intelligence Community. At least that’s how it played in Deep State officialdom. The distracted public has stopped paying attention to it. Note: neither The New York Times, the WashPo, nor CNN, have issued any righteous calls for answers in the malodorous Skripal matter. They’re all probably embarrassed that they latched on to the story and played it like “Pearl Harbor.” But no one is accountable and the net result is a Russian diplomatic presence reduced to a skeleton crew in Washington, which can’t be a great thing for mutual understanding.

So, now, the Russians and Syrians have had plenty of time to scramble their airplanes and move personnel around the landscape to await another US smackdown, and the Russians have promised to shoot down our missiles with some spooky new technology, and it looks like our side is blinking. Do we have any idea whether the Russians actually can shoot down our offensive missiles? Maybe we don’t want to know. We surely don’t want the world to know. It would be — how you say? — bad optics.

Of course, this latest uproar over the Douma poison gas incident coincided with the first day at work of National Security Advisor John Bolton, a reputed devotee of military monkey business. But it’s possible that even Mr. Bolton is embarrassed by these crude shenanigans, which just preceded his return to influence on the political scene. If he has any influence at all, perhaps he might use it to suggest that the President of the United States just shut the fuck up for a while.

Support this website by visiting Jim’s Patreon Page! https://tinyurl.com/ycozs4rm ;

http://kunstler.com/clusterfuck-nation/warmongers-remorse/ ;
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 28

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 25

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 64

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 192

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 31

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 328

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 13

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 16

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading

Top 5 Most Recently Viewed Articles

GM Partners with Barclays to Enhance Credit Card Offerings

Updated Category News Views 71

General Motors and Barclays Sign a Strategic Partnership General Motors (NYSE: GM) and Barclays have recently announced a significant long-term partnership that focuses on credit card services. This strategic agreement reflects both companies' commitment to enhancing customer experience and providing innovative financial solutions. Benefits of the New Credit Card...

Continue Reading
Enbridge Inc. Declares 3% Increase in Quarterly Dividend

Updated Category News Views 126

Enbridge Inc. Increases Quarterly Dividend by 3% Enbridge Inc. (TSX: ENB) has made a significant announcement regarding its quarterly dividend. The company declared a quarterly dividend of $0.9425 per common share, signaling a 3% increase from previous rates. This notable hike reflects Enbridge's commitment to shareholder value and marks the thirtieth consecutive year of...

Continue Reading
Jefferies Advises Caution on Biotech-Related CRO Investments

Updated Category News Views 545

CROs Confront Challenges as Biotech Market Slows In a recent analysis, Jefferies is advising investors to rethink their investments in contract research organizations (CROs), particularly those focused on biotech and early-stage research. This caution comes as the demand in the biotech sector has noticeably declined. Financial Struggles Affects Companies Jefferies has...

Continue Reading
Remarkable Cost Savings with QUELIMMUNE for Pediatric AKI

Updated Category News Views 137

Significant Economic Impact of QUELIMMUNE Therapy SeaStar Medical Holding Corporation (Nasdaq: ICU), a pioneering healthcare company, has recently published a health economic analysis that underscores the substantial financial benefits of its QUELIMMUNE therapy for pediatric patients suffering from Acute Kidney Injury (AKI). The analysis highlights an estimated average...

Continue Reading
SKF Invites Fans to Revitalize Tattoos with Brand Update

Updated Category News Views 228

SKF Invites Fans to Revitalize Tattoos with Brand Update SKF has taken an impactful step to modernize its brand identity, showcasing a fresh and dynamic look aimed at connecting with its audience more effectively. This update marks the company's first significant change to its logo since its inception in 1908, highlighting the dedication to innovation while respecting its...

Continue Reading